Search - tctmd.com

Displaying 721 - 740 of 795

Sort: Relevancy | Date

Presentation TCT 2012

Dedicated Bifurcation Stents: STENTYS Program Update

Presenter: Stefan Verheye

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

Presenter: Lawrence Garcia

October 22, 2012

Presentation TCT 2012

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

Presenter: Emmanouil Brilakis

October 22, 2012

Presentation

COBRA: Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for PAD

Presenter: 17338|Subhash Banerjee

September 12, 2012

Presentation ESC 2012

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Presenter: Tudor C. Poerner

August 27, 2012

Presentation

Effect of Biolimus-Eluting Stents with Biodegradable Polymer vs. BMS on Cardiovascular Events in AMI

Presenter: L. R?ber

August 21, 2012

Presentation

3-Year Clinical Outcomes in SORT OUT III Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

August 21, 2012

Presentation

Long-term Outcome of Stents vs. CABG in Diabetic and Nondiabetic Patients with Multivessel or Left Main CAD

Presenter: D-W Park

August 14, 2012

Presentation

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Presenter: Takeshi Kimura

July 27, 2012

Presentation

Stent Thrombosis with Everolimus-Eluting Stents

Presenter: T. Palmerini

June 14, 2012

Presentation TCT Russia 2012

Evidence Based Device Selection (Stents, Thrombectomy, etc.) for Primary PCI

Presenter: Petr Kala

May 28, 2012

Presentation

Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion

Presenter: 167498|Scott Denardo

May 24, 2012

Presentation EuroPCR 2012

Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare Metal Stents in Acute Myocardial Infarction: the COMFORTABLE AMI Trial

Presenter: 168190|Lorenz Raber

May 18, 2012

Presentation TCT Mediterranean 2012

DES Pipeline: The Evolution of Everolimus Eluting Stents Utilizing Platinum Chromium Alloy

Presenter: C. Moretti

May 04, 2012

Presentation TCT Mediterranean 2012

Bioabsorbable Stents and Polymers: Is It Prime Time?

Presenter: Eugenia Nikolsky

May 04, 2012

Presentation TCTAP 2012

Update of Dedicated Bifurcation Stents

Presenter: Martin B. Leon

April 26, 2012

Presentation TCT Russia 2012

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Presenter: Gregg W. Stone

April 26, 2012

Presentation Fellows 2012

Zotarolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Presenter: David Kandzari

April 21, 2012

Presentation Fellows 2012

Next-Generation Technologies: Bioabsorbable Stents/Polymers, Drug-Eluting Balloons, and More

Presenter: Juan Granada

April 21, 2012

Presentation Fellows 2012

First-Generation Drug-Eluting Stents: The Good, the Bad, and the Ugly

Presenter: Issam Moussa

April 21, 2012

Advertisement

Dedicated Bifurcation Stents: STENTYS Program Update

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

COBRA: Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for PAD

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Effect of Biolimus-Eluting Stents with Biodegradable Polymer vs. BMS on Cardiovascular Events in AMI

3-Year Clinical Outcomes in SORT OUT III Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Long-term Outcome of Stents vs. CABG in Diabetic and Nondiabetic Patients with Multivessel or Left Main CAD

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Stent Thrombosis with Everolimus-Eluting Stents

Evidence Based Device Selection (Stents, Thrombectomy, etc.) for Primary PCI

Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion

Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare Metal Stents in Acute Myocardial Infarction: the COMFORTABLE AMI Trial

DES Pipeline: The Evolution of Everolimus Eluting Stents Utilizing Platinum Chromium Alloy

Bioabsorbable Stents and Polymers: Is It Prime Time?

Update of Dedicated Bifurcation Stents

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Zotarolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Next-Generation Technologies: Bioabsorbable Stents/Polymers, Drug-Eluting Balloons, and More

First-Generation Drug-Eluting Stents: The Good, the Bad, and the Ugly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content